Factors related to end-of-life (EOL) chemotherapy in solid tumor (ST) patients

被引:0
|
作者
Rodriguez, Maria Alma [1 ]
DeJesus, Yvette A. [1 ]
Cheng, Lee [1 ]
Buzdar, Aman [1 ]
Burke, Thomas W. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9538
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Continuity of care for cancer patients at the end of life (EoL).
    Bascioni, R.
    Esperide, B.
    Iacopini, D.
    Basirat, F.
    Rastelli, F.
    Acito, L.
    Bisonni, R.
    Giustini, L.
    Giorgi, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [42] A holistic decision support tool for remanufacturing: end-of-life (EOL) strategy planning
    Yang, S. S.
    Nasr, N.
    Ong, S. K.
    Nee, A. Y. C.
    ADVANCES IN MANUFACTURING, 2016, 4 (03) : 189 - 201
  • [43] End-of-life (EOL) decision making in the NICU: A prospective study of physicians' perspectives
    Hellmann, J
    O'Brien, K
    McAllister, M
    Jacobs, S
    Marshall, M
    Harrison, C
    PEDIATRIC RESEARCH, 2002, 51 (04) : 42A - 43A
  • [44] From survivorship to end-of-life discussions for brain tumor patients
    Lwin, Zarnie
    NEURO-ONCOLOGY PRACTICE, 2021, 8 (03) : 231 - 232
  • [45] Differences in attitudes and beliefs toward end-of-life treatments between hematologic (Heme) and solid tumor (ST) oncology specialists
    Hui, David
    Bansal, Swati
    Park, Minjeong
    Reddy, Akhila Sunkepally
    Cortes, Jorge E.
    Fossella, Frank V.
    Bruera, Eduardo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] Comparing end-of-life care of hematologic malignancy versus solid tumor patients in a tertiary care center
    Burstein, Rachel
    Aviv, Ariel
    Even-Zohar, Noa Gross
    Nachmias, Boaz
    Haran, Arnon
    Braun, Michal
    Rottenberg, Yakir
    Shaulov, Adir
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (04) : 528 - 535
  • [47] Chemotherapy use near the end-of-life in patients with metastatic breast cancer
    Luisa Edman Kessler
    Johnny Sigfridsson
    Dora Hatzidaki
    Jonas Bergh
    Theodoros Foukakis
    Vasilios Georgoulias
    Alexios Matikas
    Breast Cancer Research and Treatment, 2020, 181 : 645 - 651
  • [48] Chemotherapy use near the end-of-life in patients with metastatic breast cancer
    Kessler, Luisa Edman
    Sigfridsson, Johnny
    Hatzidaki, Dora
    Bergh, Jonas
    Foukakis, Theodoros
    Georgoulias, Vasilios
    Matikas, Alexios
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (03) : 645 - 651
  • [49] Incidence and characterization of end-of-life (EoL) systemic anticancer therapy (SACT) in melanoma patients (pts): A monocentric experience
    Buriolla, S.
    Pravisano, F.
    Costa, J.
    Alberti, M.
    Bortolus, G.
    Zapelloni, G.
    De Pieri, G.
    Targato, G.
    Pascoletti, G.
    Puglisi, F.
    Fasola, G.
    Minisini, A. M. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S887 - S887
  • [50] Integration of Infection Management and End-of-Life (EoL) Related Physical Symptom Managements in Physician Orders for Life-Sustaining Treatments (POLST)
    Tark, Aluem
    Agarwal, Mansi
    Stone, Patricia
    NURSING RESEARCH, 2019, 68 (02) : E102 - E102